Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

L'immunogénétique et la production d'anticorps de haute affinité

EF 2020-21

Résumé
The immune system is complex and consists of several white blood cells that provide defense against microorganisms foreign to our body such as parasites, fungi, viruses, and bacteria. To eliminate these foreign bodies, the immune system sets up responses involving the production of antibodies. These antibodies can recognize and facilitate the elimination of the intruder, as well as protect us from a secondary infection to the same foreign body. As we know, each of us responds differently to an infection explaining why, for a given disease, some are more ill than others. Variations in the genetic code of each individual partly contribute to this divergence. Dr. Lesage's group has shown that the genetic variability driving immune differences in humans can be paralleled by studying the immune system in multiple genetically divergent mouse strains. We hypothesize that the induction of immune responses leading to effective antibody production will differ for each mouse strain. To define the genetic underpinnings driving this difference, we will vaccinate various types of mice with different foreign bodies such as sheep red blood cells. The efficacy of the immune response generated to these foreign bodies will be quantified in each mouse. This project will allow us to determine the impact of genetic variability on the immune response and to identify genes that facilitate better immune responses. The information gained during this project will enable us to improve vaccination protocols, anti-cancer responses, production of antibodies for therapeutic purposes, and more, consequently improving the health of Canadians.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449511
Name
Aubin Anne-Marie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
L'immunogénétique et la production d'anticorps de haute affinité
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anticorps; Centres Germinatifs; Génétique; Immunisation; Immunologie; Lymphocytes; Maturation D'Affinité Des Anticorps; Modèles Murins; Réponse Humorale; Variants Génétiques
Abstract
The immune system is complex and consists of several white blood cells that provide defense against microorganisms foreign to our body such as parasites, fungi, viruses, and bacteria. To eliminate these foreign bodies, the immune system sets up responses involving the production of antibodies. These antibodies can recognize and facilitate the elimination of the intruder, as well as protect us from a secondary infection to the same foreign body. As we know, each of us responds differently to an infection explaining why, for a given disease, some are more ill than others. Variations in the genetic code of each individual partly contribute to this divergence. Dr. Lesage's group has shown that the genetic variability driving immune differences in humans can be paralleled by studying the immune system in multiple genetically divergent mouse strains. We hypothesize that the induction of immune responses leading to effective antibody production will differ for each mouse strain. To define the genetic underpinnings driving this difference, we will vaccinate various types of mice with different foreign bodies such as sheep red blood cells. The efficacy of the immune response generated to these foreign bodies will be quantified in each mouse. This project will allow us to determine the impact of genetic variability on the immune response and to identify genes that facilitate better immune responses. The information gained during this project will enable us to improve vaccination protocols, anti-cancer responses, production of antibodies for therapeutic purposes, and more, consequently improving the health of Canadians.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Aubin, Anne-Marie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~